Alyeska Investment Group’s MediWound MDWD Stock Holding History

Alyeska Investment Group’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-127,729	Closed	-$1.36M	–	611
2023 Q3	$1.36M	Sell	127,729 -22,271	-15%	-$205K	0.01%	409
2023 Q2	$1.6M	Hold	150,000	–	–	0.01%	421
2023 Q1	$2M	Buy	+150,000	New	+$1.89M	0.02%	352
2018 Q2	–	Sell	-28,236	Closed	-$1.03M	–	499
2018 Q1	$1.03M	Sell	28,236 -9,291	-25%	-$292K	0.01%	390
2017 Q4	$1.17M	Sell	37,527 -19,616	-34%	-$660K	0.01%	377
2017 Q3	$2.14M	Buy	+57,143	New	+$2.52M	0.02%	357

Other funds holding MDWD

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Alyeska Investment Group's MDWD Position: Q4 2023 in Review

Alyeska Investment Group sold out of MediWound (MDWD) in Q4 2023, closing a stake of 127,729 shares — an estimated $1.36M sold.

Alyeska Investment Group first reported a position in MDWD in Q3 2017 and held it in 6 quarters. The position peaked at $2.14M in Q3 2017. 22 funds tracked by Wall St. Rank hold MDWD as of Q4 2023.

Alyeska Investment Group reported no remaining MediWound position as of Q4 2023 after selling out during the quarter.
Alyeska Investment Group sold 127,729 MediWound shares in Q4 2023, an estimated $1.36M.
Alyeska Investment Group first reported a position in MediWound in Q3 2017 and held it in 6 quarters.
Alyeska Investment Group's MediWound position peaked at $2.14M in Q3 2017.
22 funds tracked by Wall St. Rank held MediWound as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.